← Leaderboards
Blaine H. M. Mooers
University Of Oklahoma Hlth Sciences Ctr
$2,541,882
Attributed
$3,835,266
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $633.3K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,835,266 · 4
By mechanism
R01$3,389,910 · 2
P20$445,356 · 2
Top collaborators
- Jie Wu5 shared
- Vivek Subbiah3 shared
- Jordi Rodon Ahnert2 shared
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Adam Zlotnick$11,682,701
- Marie H Hanigan$4,314,713
- Vivek Subbiah$600,026
- Jordi Rodon Ahnert$390,833
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureProteinsRoentgen RaysBaseMalignant NeoplasmsInsightDesignMolecular BiologyFoundationsBiologicalLaboratoriesX-Ray CrystallographyVariantEffective TherapySiteBiologyComplex3-DimensionalCrystallizationPharmaceutical PreparationsThree Dimensional StructureInstrumentCaliberCenters Of Research Excellence
Grant awards (15)
Blocking tumor progression in therapy-responsive RET aberration-associated cancer$369,899
R01 · FY2024 · CA
Blocking tumor progression in therapy-responsive RET aberration-associated cancer$382,199
R01 · FY2023 · CA
Blocking tumor progression in therapy-responsive RET aberration-associated cancer$382,759
R01 · FY2022 · CA
Blocking tumor progression in therapy-responsive RET aberration-associated cancer$391,096
R01 · FY2021 · CA
Laboratory of Biomolecular Structure and Function$24,838
P20 · FY2021 · GM · contact PI
Blocking tumor progression in therapy-responsive RET aberration-associated cancer$414,123
R01 · FY2020 · CA
Laboratory of Biomolecular Structure and Function$21,440
P20 · FY2020 · GM · contact PI
Laboratory of Biomolecular Structure and Function$21,440
P20 · FY2019 · GM · contact PI
Laboratory of Biomolecular Structure and Function$21,440
P20 · FY2018 · GM · contact PI
Laboratory of Biomolecular Structure and Function$87,698
P20 · FY2017 · GM · contact PI
The role of non-canonical base pairs in RNA editing$364,834
R01 · FY2015 · AI · contact PI
OUHSC Macromolecular X-ray Facility$268,500
P20 · FY2015 · GM · contact PI
The role of non-canonical base pairs in RNA editing$364,853
R01 · FY2014 · AI · contact PI
The role of non-canonical base pairs in RNA editing$343,012
R01 · FY2013 · AI · contact PI
The role of non-canonical base pairs in RNA editing$377,135
R01 · FY2012 · AI · contact PI